MEKK1 controls matrix degradation and tumor cell dissemination during metastasis of polyoma middle-T driven mammary cancer

Oncogene

Volumn 25, Issue 36, 2006, Pages 4998-5010

  Cuevas, B D ^a   Winter Vann, A M ^a   Johnson, N L ^a   Johnson, G L ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Kinase; Knockout; MAPK; Metastasis; Proteinase

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; SMALL INTERFERING RNA; UROKINASE; VIRUS MIDDLE T ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CELL MIGRATION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MOUSE; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; TRANSGENE; TRANSGENIC MOUSE; TUMOR CELL;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; BASE SEQUENCE; DISEASE PROGRESSION; DNA PRIMERS; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MAP KINASE KINASE KINASE 1; MICE; MICE, KNOCKOUT; NEOPLASM METASTASIS; RNA, SMALL INTERFERING;

EID: 33747360733     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209507     Document Type: Article

References (49)

1. Ahmed F, Wyckoff J, Lin EY, Wang W, Wang Y, Hennighausen L et al. (2002). Cancer Res 62: 7166-7169.
2. Almholt K, Lund LR, Rygaard J, Nielsen BS, Dano K, Romer J et al. (2005). Int J Cancer 113: 525-532.
3. Andreasen PA, Kjoller L, Christensen L, Duffy MJ. (1997). Int J Cancer 72: 1-22.
4. Balduyck M, Zerimech F, Gouyer V, Lemaire R, Hemon B, Grard G et al. (2000). Clin Exp Metastasis 18: 171-178.
5. Bianco Jr FJ, Gervasi DC, Tiguert R, Grignon DJ, Pontes JE, Crissman JD et al. (1998). Clin Cancer Res 4: 3011-3016.
6. Bogenrieder T, Herlyn M. (2003). Oncogene 22: 6524-6536.
7. Bronzert DA, Pantazis P, Antoniades HN, Kasid A, Davidson N, Dickson RB et al. (1987). Proc Natl Acad Sci USA 84: 5763-5767.
8. Bugge TH, Lund LR, Kombrinck KK, Nielsen BS, Holmback K, Drew AF et al. (1998). Oncogene 16: 3097-3104.
9. Cardiff RD, Anver MR, Gusterson BA, Hennighausen L, Jensen RA, Merino MJ et al. (2000). Oncogene 19: 968-988.
10. Christensen L, Wiborg Simonsen AC, Heegaard CW, Moestrup SK, Andersen JA, Andreasen PA. (1996). Int J Cancer 66: 441-452.
11. Cirillo G, Casalino L, Vallone D, Caracciolo A, De Cesare D, Verde P. (1999). Mol Cell Biol 19: 6240-6252.
12. Cuevas BD, Abell AN, Witowsky JA, Yujiri T, Johnson NL, Kesavan K et al. (2003). Embo J 22: 3346-3355.
13. Cuevas BD, Uhlik MT, Garrington TP, Johnson GL. (2005). Oncogene 24: 801-809.
14. Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T et al. (1993). Cancer Res 53: 5365-5369.
15. D'Orazio D, Besser D, Marksitzer R, Kunz C, Hume DA, Kiefer B et al. (1997). Gene 201: 179-187.
16. Duffy MJ. (2004). Ann Clin Biochem 41: 370-377.
17. Duffy MJ, Duggan C. (2004). Clin Biochem 37: 541-548.
18. Egeblad M, Werb Z. (2002). Nat Rev Cancer 2: 161-174.
19. el Yazidi I, Boilly-Marer Y. (1995). Anticancer Res 15: 783-790.
20. Fanger GR, Johnson NL, Johnson GL. (1997). Embo J 16: 4961-4972.
21. Fidler IJ. (1991). Acta Oncol 30: 668-675.
22. Fincham VJ, James M, Frame MC, Winder SJ. (2000). Embo J 19: 2911-2923.
23. Frederiks WM, Mook OR. (2004). J Histochem Cytochem 52: 711-722.
24. Fuchs SY, Dolan L, Davis RJ, Ronai Z. (1996). Oncogene 13: 1531-1535.
25. Glading A, Chang P, Lauffenburger DA, Wells A. (2000). J Biol Chem 275: 2390-2398.
26. Guy CT, Cardiff RD, Muller WJ. (1992). Mol Cell Biol 12: 954-961.
27. Hamasaki T, Hattori T, Kimura G, Nakazawa N. (1998). Urol Res 26: 371-376.
28. Huang C, Jacobson K, Schaller MD. (2004). J Cell Sci 117: 4619-4628.
29. Huang C, Rajfur Z, Borchers C, Schaller MD, Jacobson K. (2003). Nature 424: 219-223.
30. Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, Itohara S. (1998). Cancer Res 58: 1048-1051.
31. Karin M, Liu Z, Zandi E. (1997). Curr Opin Cell Biol 9: 240-246.
32. Lapidus RG, Nass SJ, Davidson NE. (1998). J Mammary Gland Biol Neoplasia 3: 85-94.
33. Lijnen HR, Van Hoef B, Lupu F, Moons L, Carmeliet P, Collen D. (1998). Arterioscler Thromb Vasc Biol 18: 1035-1045.
34. Lin EY, Jones JG, Li P, Zhu L, Whitney KD, Muller WJ et al. (2003). Am J Pathol 163: 2113-2126.
35. Nielsen BS, Sehested M, Timshel S, Pyke C, Dano K. (1996). Lab Invest 74: 168-177.
36. Nielsen BS, Sehested M, Duun S, Rank F, Timshel S, Rygaard J et al. (2001). Lab Invest 81: 1485-1501.
37. Manders P, Tjan-Heijnen VC, Span PN, Grebenchtchikov N, Geurts-Moespot A, van Tienoven DT et al. (2004). Cancer 101: 486-494.
38. Meijer-van Gelder ME, Look MP, Peters HA, Schmitt M, Brunner N, Harbeck N et al. (2004). Cancer Res 64: 4563-4568.
39. Scacheri PC, Rozenblatt-Rosen O, Caplen NJ, Wolfsberg TG, Umayam L, Lee JC et al. (2004). Proc Natl Acad Sci USA 101: 1892-1897.
40. Schweinitz A, Steinmetzer T, Banke IJ, Arlt MJ, Sturzebecher A, Schuster O et al. (2004). J Biol Chem 279: 33613-33622.
41. Sidenius N, Blasi F. (2003). Cancer Metastasis Rev 22: 205-222.
42. Sieuwerts AM, Klijn JG, Henzen-Logmans SC, Foekens JA. (1999). Breast Cancer Res Treat 55: 9-20.
43. Stamenkovic I. (2000). Semin Cancer Biol 10: 415-433.
44. Tanaka Y, Kobayashi H, Suzuki M, Kanayama N, Terao T. (2004). Gynecol Oncol 94: 725-734.
45. Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, Parsons JT et al. (2004). Nat Cell Biol 6: 154-161.
46. Westermarck J, Kahari VM. (1999). Faseb J 13: 781-792.
47. Witowsky J, Abell A, Johnson NL, Johnson GL, Cuevas BD. (2003). J Biol Chem 278: 5941-5946.
48. Yujiri T, Sather S, Fanger GR, Johnson GL. (1998). Science 282: 1911-1914.
49. Yujiri T, Ware M, Widmann C, Oyer R, Russell D, Chan E et al. (2000). Proc Natl Acad Sci USA 97: 7272-7277.